Watson Pharmaceuticals Inc. unit, Watson Laboratories Inc. - Florida, has received FDA approval for its abbreviated new drug application for generic Cardizem LA product. Corona, California-based Watson intends to launch its generic version of Cardizem LA immediately.

Diltiazem Hydrochloride Extended-Release tablets, which are the generic equivalent to Biovail Laboratories International SRL's, a unit of Biovail Corp., Cardizem LA product, are indicated for the treatment of hypertension.